Jing Xiong

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Gene Expression

Top Venues

Hepatology (Baltimore, Md.)

British journal of pharmacology

University of Michigan

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan Aug 06 2017

United States

Research Scientist :: Life Sciences Institutes

Nanjing Medical University Aug 20 2011 - Aug 30 2016

China

Assistant Professor :: Department of Pharmacology

Education History

China Pharmaceutical University Sep 01 2006 - Jul 01 2011

China

PHD

Mayo Clinic Research Minnesota Aug 01 2009 - Sep 06 2010

United States

PHD

Publications

Danyu Du, Mengyao Qin, Li Shi, Chan Liu, Jingwei Jiang, Zhengguang Liao, Hongxv Wang, Zhibo Zhang, Li Sun, Hui Fan, Zhengrui Liu, Hong Yu, Hongyang Li, Jun Peng, Shengtao Yuan, Mei Yang, Jing Xiong
RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression. Oncogene (2023)
Mengyao Qin, Yu Xin, Yong Bian, Xuan Yang, Tao Xi, Jing Xiong
Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis. Cells 11 (2) (2022)
Jing Xiong, Tongyu Liu, Lin Mi, Henry Kuang, Xuelian Xiong, Zhimin Chen, Siming Li, Jiandie D Lin
hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis. Hepatology (Baltimore, Md.) 71 (4) (2020)
Wenjing Luo, Yu Xin, Xia Zhao, Feng Zhang, Changqing Liu, Hongwei Fan, Tao Xi, Jing Xiong
Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor. British journal of pharmacology 174 (8) (2017)